Research Papers

25 of 11502 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
A study on out-of-field leakage of an accelerator-based neutron beam for boron neutron capture therapy.
You ZF; Huang CK; Liu YH.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Tumor alkalization therapy: misconception or good therapeutics perspective? - the case of malignant ascites.
Bogdanov A; Verlov N; Bogdanov A; Burdakov V; Semiletov V; Egorenkov V; Volkov N; Moiseyenko V.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Inhibition of OCT4 binding at the <i>MYCN</i> locus induces neuroblastoma cell death accompanied by downregulation of t…
Nakatani K; Kogashi H; Miyamoto T; Setoguchi T; Sakuma T; Kugou K; Hasegawa Y; Yamamoto T; Hippo Y; Suenaga Y.
Front Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune check…
Wang J; Guo H; Yang J; Mao J; Wang Y; Yan X; Guo H.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Advanced lung cancer inflammation index predicts overall survival of hepatocellular carcinoma after hepatectomy.
Wen YZ; Liu GM; Liao JP; Xu JW.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Malignant mixed mullerian tumors: a SEER database review of rurality and treatment modalities on disease outcome.
Zadeh N; Bhatt A; Sripiparu V; Pasli M; Edwards G; Larkins MC; Peach MS.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Management of acral lentiginous melanoma: current updates and future directions.
Dugan MM; Perez MC; Karapetyan L; Zager JS.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed…
Callegari AJ; Tsang J; Park S; Swartzfager D; Kapoor S; Choy K; Lim S.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and tr…
Chen B; Zhao L; Yang R; Xu T.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical significance of serum high sensitive C-reactive protein/albumin ratio in primary prostate biopsy.
Chen X; Li Y; Li G; Zhang X; Xie G; Huang Y; Yin H.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advan…
Li S; Manochakian R; Chen R; Patel J; Inampudi JV; Hiren KR; Zhao Y; Lou Y.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation th…
Zhang H; Sheng S; Qiao W; Han M; Jin R.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and ne…
Brandt A; Schultheiss C; Klinghammer K; Schafhausen P; Busch CJ; Blaurock M; Hinke A; Tometten M; Dietz A; Müller-Richter U; Hahn D; Alt J; Stein A; Binder M.
Front Oncol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Diverse temporal and spatial mechanisms work, partially through Stanniocalcin-1, V-ATPase and senescence, to activate t…
Zhang H; Song J; Ward R; Han Y; Hunt A; Shriwas P; Steed A; Edwards C; Cao Y; Co M; Chen X.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Interpretable machine learning model to predict surgical difficulty in laparoscopic resection for rectal cancer.
Yu M; Yuan Z; Li R; Shi B; Wan D; Dong X.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from C…
Huang A; Yang Y; Sun Z; Hong H; Chen J; Gao Z; Gu J.
Front Oncol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Most deprived Louisiana census tracts have higher hepatocellular carcinoma incidence and worse survival.
Ratnapradipa KL; Li T; Hsieh MC; Tenner L; Peters ES.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Loss of symbiotic and increase of virulent bacteria through microbial networks in Lynch syndrome colon carcinogenesis.
Sadeghi M; Mestivier D; Carbonnelle E; Benamouzig R; Khazaie K; Sobhani I.
Front Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Distinct roles for interleukin-23 receptor signaling in regulatory T cells in sporadic and inflammation-associated carc…
Jacobse J; Pilat JM; Li J; Brown RE; Kwag A; Buendia MA; Choksi YA; Washington MK; Williams CS; Markham NO; Short SP; Goettel JA.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of …
Sun Y; Wang X; Yao L; He R; Man C; Fan Y.
Front Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China.
Chen J; Zhang M; Li K; Duan Y; Zeng J; Li Q; Wang D; Song L; Li Q; Yin R.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid…
Xiao J; Chen H; Ge J; Liu T.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.
Vecchio E; Marino R; Mimmi S; Canale C; Caiazza C; Arcucci A; Ruocco MR; Schiavone M; Santamaria G; Palmieri C; Iaccino E; Mallardo M; Quinto I; Fiume G.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer.
Fultang N; Schwab AM; McAneny-Droz S; Grego A; Rodgers S; Torres BV; Heiser D; Scherle P; Bhagwat N.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Antibody-mediated targeting of Claudins in cancer.
Vonniessen B; Tabariès S; Siegel PM.
Front Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared